Effective July 1, 2010, the Ontario government has fixed the price of generic medicines at 25% of the price of the equivalent brand name drug. In addition, approximately $800 million a year currently paid by generic drug companies to pharmacies in rebates will be banned. As Ontario struggles to contain the costs of health care, it seems that arbitrary price controls are not the answer. The system needs a overhaul.